Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Brand

Showing results (91-100 of 163) with videos related to

Pageof 17
Sort By:
Neuroendocrinology|February 21, 2007
The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cellsKathrin Zitzmann, Enrico N De Toni, Stephan Brand, et al.
Inflammatory Bowel Diseases|August 12, 2015
Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype StatusJohannes Stallhofer, Matthias Friedrich, Astrid Konrad-Zerna, et al.
Biochemical and Biophysical Research Communications|April 27, 2005
SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29Stephan Brand, Kathrin Zitzmann, Julia Dambacher, et al.
Inflammatory Bowel Diseases|September 20, 2011
Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgeryMichael S Kasparek, Andreas Bruckmeier, Florian Beigel, et al.
Clinical and Translational Gastroenterology|January 14, 2022
Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin ExpressionJohannes Stallhofer, Lisa Veith, Julia Diegelmann, et al.
Digestion|December 20, 2011
Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel diseaseFlorian Beigel, Beate Löhr, Rüdiger P Laubender, et al.
Gastrointestinal Endoscopy|September 26, 2002
Detection of high-grade dysplasia in Barrett's esophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescenceStephan Brand, Thomas D Wang, Kevin T Schomacker, et al.
The American Journal of Gastroenterology|January 13, 2006
Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease PhenotypeStephan Brand, Katrin Hofbauer, Julia Dambacher, et al.
Cancer Research|May 19, 2007
SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cellsKathrin Zitzmann, Stephan Brand, Enrico N De Toni, et al.
Inflammatory Bowel Diseases|November 23, 2006
Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohn's disease in clinical practice: results of a prospective studyJulia Seiderer, Stephan Brand, Karin A Herrmann, et al.
Pageof 17

Showing results (91-100 of 163) with videos related to

Sort By:
Pageof 17
Neuroendocrinology|February 21, 2007
The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cellsKathrin Zitzmann, Enrico N De Toni, Stephan Brand, et al.
Inflammatory Bowel Diseases|August 12, 2015
Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype StatusJohannes Stallhofer, Matthias Friedrich, Astrid Konrad-Zerna, et al.
Biochemical and Biophysical Research Communications|April 27, 2005
SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29Stephan Brand, Kathrin Zitzmann, Julia Dambacher, et al.
Inflammatory Bowel Diseases|September 20, 2011
Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgeryMichael S Kasparek, Andreas Bruckmeier, Florian Beigel, et al.
Clinical and Translational Gastroenterology|January 14, 2022
Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin ExpressionJohannes Stallhofer, Lisa Veith, Julia Diegelmann, et al.
Digestion|December 20, 2011
Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel diseaseFlorian Beigel, Beate Löhr, Rüdiger P Laubender, et al.
Gastrointestinal Endoscopy|September 26, 2002
Detection of high-grade dysplasia in Barrett's esophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescenceStephan Brand, Thomas D Wang, Kevin T Schomacker, et al.
The American Journal of Gastroenterology|January 13, 2006
Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease PhenotypeStephan Brand, Katrin Hofbauer, Julia Dambacher, et al.
Cancer Research|May 19, 2007
SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cellsKathrin Zitzmann, Stephan Brand, Enrico N De Toni, et al.
Inflammatory Bowel Diseases|November 23, 2006
Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohn's disease in clinical practice: results of a prospective studyJulia Seiderer, Stephan Brand, Karin A Herrmann, et al.
Pageof 17